News

You can filter the posts based on tags:

ILH and IIT Hyderabad establish Indo–German Bioengineering Centre of Excellence for Lung Health

The Institute for Lung Health (ILH), Justus Liebig University Giessen, and the Indian Institute of Technology Hyderabad (IITH) have established India’s first dedicated Bioengineering Centre for Lung Health.

2026-01-06

How Influenza Weakens Lung Immunity

Influenza infections can severely compromise the lung’s immune defense, making patients more susceptible to secondary bacterial infections. DZL scientists have identified a key mechanism by which specialized immune cells in the lungs are depleted during severe influenza, revealing new potential targets for therapeutic intervention.

2025-12-02

New issue of the DZG magazine SYNERGIE on the topic of “Regenerative Medicine”

Cell and gene therapies are transforming medicine – from cancer and heart failure to infections. The new SYNERGIE highlights how the German Centers for Health Research are bringing these approaches from the laboratory to clinical practice.

2025-11-19

ERS–COPD-iNET: International Research Seminar Highlights Opportunities for Early Intervention in COPD

More than 120 clinicians, researchers, and patient representatives gathered in Prague for the ERS/COPD-iNET Seminar to discuss new scientific and therapeutic approaches to COPD.

2025-10-09

New Lung Disease Atlas: Single-Cell Analysis of 900 Drug Interventions

At the Helmholtz Center Munich, Prof. Herbert Schiller and Prof. Fabian Theis, DZL scientists at the CPC-M site, have launched an ambitious project in collaboration with Parse Biosciences to create one of the most comprehensive lung disease “perturbation atlases” to date.

2025-10-02

Prof. Soni Savai Pullamsetti Receives ERS Mid-Career Gold Medal

ILH scientist Prof. Soni Savai Pullamsetti has received the ERS Mid-Career Gold Medal in Pulmonary Circulation. The award was presented during this year’s ERS Congress in Amsterdam.

2025-09-06

New Horizons in Pulmonary Fibrosis Treatment Through AI and Single-Cell Analysis

ILH/DZL researchers are using single-cell genomics and artificial intelligence to study the complex mechanisms of idiopathic pulmonary fibrosis. With funding of around one million euros, the project aims to gain new insights and pave the way for future therapeutic approaches.

2025-08-20

New Strategies to Overcome Immunotherapy Resistance in Lung Cancer

Latest research shows: despite ongoing challenges, the combination of innovative therapeutic strategies and precise diagnostics opens up new perspectives for people with advanced NSCLC.

1 2 3 … 9 Next »

Archives